Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
Is measuring total IgG levels during acute myasthenia gravis exacerbations helpful for monitoring treatment or guiding the number of plasma exchange procedures?
Related Questions
How do you treat benign fasciculation syndrome?
Would you add immunosuppression in ocular myasthenia gravis patients who are symptomatically well-controlled on pyridostigmine?
When do you utilize rozanolixizumab in patients with myasthenia gravis?
How do you approach sequentially tapering combination therapy (i.e., IVIG, mycophenolate, rituximab) for dermatomyositis that is in remission?
How do you reconcile the benefits of high glycemic load to slow ALS disease progression with previous data on the increased risk for ALS associated with diabetes mellitus?
How do you counsel patients who wish to travel to high altitudes with myasthenia gravis?
Beyond fatigability, what distinctive features of diplopia characterize myasthenia gravis?
What typical lab tests do you send off for evaluation of neuropathy?
How do you approach managing nausea and GI side effects when initiating methotrexate?
What nutritional supplements do you recommend for patients with ALS?
